Liquidia Corporation Common Stock (LQDA)
Publicly reported company facts and saved market data for Liquidia Corporation Common Stock (LQDA), with sources and as-of times. Saved data is not a live quote.
Company profile
Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases. The company's current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT Technology. PRINT enabled the creation of YUTREPIA (treprostinil) inhalation powder, a drug approved in 2025 for the treatment of PAH. YUTREPIA is currently under development for other indications, including SSc-RP and PH-COPD. The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice daily with a next-generation nebulizer.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.4B
- Incorporated in
- United States
- Company website
- www.liquidia.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $33.0102
- Reported change
- +23.13%
- Reported volume
- 21,143,410
- Latest market time
Short interest
- Reported short interest
- 12,640,721 shares
- Settlement date
- Source
- Nasdaq
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 27.04 | 27.40 | 26.13 | 26.81 | 7,653,314 | |
| 29.27 | 30.86 | 27.27 | 27.67 | 4,414,322 | |
| 27.06 | 28.53 | 26.66 | 27.38 | 3,616,981 | |
| 26.34 | 29.35 | 26.34 | 28.02 | 5,259,541 | |
| 25.55 | 27.33 | 24.59 | 26.68 | 6,987,842 | |
| 27.95 | 28.30 | 25.76 | 25.91 | 5,313,684 | |
| 28.07 | 28.48 | 25.92 | 27.64 | 7,759,906 | |
| 26.69 | 29.18 | 26.31 | 28.64 | 8,404,136 | |
| 23.96 | 28.10 | 22.31 | 27.99 | 21,573,270 | |
| 70.54 | 71.93 | 29.86 | 30.26 | 22,953,200 |
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue